The clean water technology firm reported a reduced loss but significantly lower revenue following strategic asset sales. It's now focusing on promising PFAS remediation and produced water markets amid ongoing financial challenges.
The clean water technology company welcomes the EPA's new plan to tackle PFAS contamination, which could lead to increased activity and investment in the PFAS remediation market.
The clean water technology company has granted share options to its top executives.
The clean water technology company reports a successful water trial in the US and upcoming PFAS trials, while also confirming an earn-out from the sale of its Saudi Arabia business and revising FY 2025 revenue guidance due to tariffs.
The clean water technology company has appointed a new nominated adviser and sole broker, Cavendish Capital Markets Limited.
The clean water technology company provides a year-end update, reporting continued progress in its core markets and some positive contract wins, but lacking detailed financial information.
Clean water technology company schedules investor presentation, with potential for upside based on valuation.
Clean water technology company MYCELX sees revenue and profitability decline, but progresses on growth initiatives.
The clean water technology company revises its 2024 revenue forecast significantly lower due to a delay in a major project, though the impact on cash flow is minimal.
Clean water technology company sees reduced institutional investment, but fundamentals remain strong.